MCL1 and cancer: Therefore, TRIM17 may be involved in the chemoresistance of cancer cells that exhibit a survival dependency on BCL2A1 whereas it would increase the sensitivity of tumors depending on MCL1, due to its opposite effects on these two antiapoptotic proteins (see above).